Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q4 2023 Earning

Operator: Welcome, everyone, to the Matinas BioPharma 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode.

Related Keywords

New Jersey , United States , American , America , Julian Harrison , Terri Matkovits , Terry Ferguson , Asia Pacific , Keith Kucinski , Jerome Jabbour , Matinas Biopharma , James Ferguson , Jerry Jabbour , Robert Leboyer , Theresa Matkovits , Jody Cain , Exchange Commission , Compassionate Expanded Use Access Program , Genentech , New York Stock Exchange , York Stock Exchange , Matinas Biopharma Holdings Inc , Matinas Biopharma Holdings , Call Transcript March , Biopharma Holdings , Results Conference , Chief Executive Officer , Chief Development Officer , Chief Medical Officer , Chief Financial , Investor Relations , New York Stock , South America , Middle East , Expanded Use Access Program , Chief Medical , Working Countries , Diamonds For Engagement , Noble Capital ,